2022 ICRF-City of Hope Jacki & Bruce Barron Cancer Research Scholars’ Program Symposium

Moderator: Nancy Maizels, PhD
Chair, ICRF International Scientific Council

Training eosinophils, specialized cells of the immune system, to fight metastatic lung cancer
*Ariel Munitz, PhD, Tel Aviv University
Hua Yu, PhD, City of Hope

How the lung cancer microbiome affects the response to treatment
*Ravid Straussman, MD, PhD, Weizmann Institute of Science
Dan Raz, MD, City of Hope

Targeting epigenetic mechanisms to treat T-cell lymphoma
*Christiane Querfeld, MD, PhD, City of Hope
Emmilia Hodak, MD, Rabin Medical Center

CD84 as a therapeutic target in multiple myeloma
*Idit Shachar, PhD, Weizmann Institute of Science
Flavia Pichiorri, PhD, City of Hope

A new target for treating lymphoma, TCF-1
*Zuoming Sun, PhD, City of Hope
Noah Isakov, PhD, Ben-Gurion University of the Negev

Metabolic engineering to improve T-cell-mediated immunotherapy
*Tomer Shlomi, PhD, Technion, Israel Institute of Technology
Saul Priceman, PhD, City of Hope

Improving treatment of pancreatic cancer by targeting pyridine metabolism
*Ziv Gil, MD, PhD, Rambam Health Care Campus
Laleh Melstrom, MD, City of Hope

Overlooked mutations – a new target for therapy of breast cancer and other cancers
*Erez Levanon, PhD, Bar-Ilan University
Kevin Morris, PhD, City of Hope**

Using metallocorroles to diagnose and treat malignant melanoma
*John Termini, PhD, City of Hope
Zeev Gross, PhD, Technion, Israel Institute of Technology